DC Chemicals

All products / DC7542

BQ-788
CAT. NO. DC7542

BQ-788

Pack sizes and prices

Pack sizePrice
100 mg$1,250 USDRequest a quote →
250 mg$2,500 USDRequest a quote →
1 g$5,000 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

BQ-788 (sodium salt) is a potent and selective ETB receptor antagonist, inhibiting ET-1 binding to ETB receptors with an IC50 of 1.2 nM in human Girrardi heart cells.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC7542
Product nameBQ-788
CAS156161-89-6
Molecular formulaC34H50N5NaO7
Molecular weight663.779880046844
Purity>98%
SMILES[Na+].CCCC[C@@H](N(C([C@@H](NC(N1[C@H](C)CCC[C@@H]1C)=O)CC(C)(C)C)=O)C([C@@H](CC1=CN(C(OC)=O)C2=CC=CC=C12)N)=O)C([O-])=O

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — BQ-788 (DC7542)

Source references

[1]. Okada M, et al. BQ-788, a selective endothelin ET(B) receptor antagonist. Cardiovasc Drug Rev. 2002 Winter;20(1):53-66. [2]. Sargent CA, et al. Effect of endothelin antagonists with or without BQ 788 on ET-1 responses in pithed rats. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S216-8. [3]. Fattori V, et al. Differential regulation of oxidative stress and cytokine production by endothelin ETA and ETB receptors in superoxide anion-induced inflammation and pain in mice. J Drug Target. 2016 Oct 5:1-27

Related research products